| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238675 consisting of a substantially uncharged antisense oligomer with ratio of uncharged linkages to charged linkages in the oligomer is at least 4:1, preferably at least 5:1, and more preferably at least 8:1 |
| 07/03/2007 | US7238670 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 07/03/2007 | US7238666 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/03/2007 | US7238377 Use of an oil of the gourd family for inhibiting 5 alpha-reductase activity |
| 07/03/2007 | CA2433177C Hypoallergenic and non-irritant skin care formulations |
| 07/03/2007 | CA2350884C Topical compositions comprising ascomycins |
| 07/03/2007 | CA2278798C Aminobenzophenones as inhibitors of interleukin and tnf |
| 07/03/2007 | CA2266048C Topical composition and method for enhancing lipid barrier synthesis |
| 07/03/2007 | CA2244662C Antifungal agents |
| 07/03/2007 | CA2133607C Corticoid -17,21-dicarboxylic esters and corticosteroid 17-caboxylic esters 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 07/03/2007 | CA2130943C Corticosteroid 17-alkyl carbonate 21-[o]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
| 06/28/2007 | WO2007073303A2 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 06/28/2007 | WO2007072965A1 Angiogenesis inhibitor and utilization of the same |
| 06/28/2007 | WO2007072923A1 Preparation for external use having improved temporal stability of steroid |
| 06/28/2007 | WO2007072909A1 NOVEL OLIGONUCLEOTIDE AND NF-κB DECOY COMPRISING THE SAME |
| 06/28/2007 | WO2007072866A1 Anti-ilt7 antibody |
| 06/28/2007 | WO2007072764A1 Ce forming/maturing agent, parakeratosis inhibitor, skin barrier function recovery accelerator, and skincare composition for external application to skin |
| 06/28/2007 | WO2007072178A1 Novel proline-derivative based cosmetological and/or dermatological compositions and uses thereof |
| 06/28/2007 | WO2007071876A1 Composition of inverse emulsion type comprising ivermectin, and uses thereof in cosmetics and dermatology |
| 06/28/2007 | WO2007071540A1 Wound healing composition comprising substances obtained from diptera larvae |
| 06/28/2007 | WO2007070961A1 Mif inhibitors |
| 06/28/2007 | WO2007051805A3 Use of ceacam8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
| 06/28/2007 | WO2007025186A3 Hydrazone agents to treat cutaneous lesions |
| 06/28/2007 | US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) |
| 06/28/2007 | US20070149619 Anti-aging agent |
| 06/28/2007 | US20070149574 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/28/2007 | US20070149563 N-(1-Azabicyclo[2.2.2]oct-3-yl)(2-(3-pyridyl)thiazole-4-carboxamide); nicotinic acetylcholine receptor ligands; psychotic and intellectual impairment disorders; antidepressant, anxiolytic agent; Alzheimer's disease, cognitive or attention disorders |
| 06/28/2007 | US20070149448 chronic ulcers; cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148226 Mahonia aquifolim extract, extraction process and pharmaceutical composition containing the same |
| 06/28/2007 | US20070148197 Treating inflammation with ondansetron and pharmaceutical compositions comprised thereof |
| 06/28/2007 | US20070148158 Rationally designed heparinases derived from heparinase II |
| 06/28/2007 | US20070148142 Pharmaceutical composition for treatment of wounds containing blood plasma or serum |
| 06/28/2007 | US20070148123 Substances and agents for positively influencing collagen |
| 06/28/2007 | US20070148108 Stable vitamin b6 derivative |
| 06/28/2007 | US20070148093 Non-terminal method of identifying anti-migraine compounds |
| 06/28/2007 | DE202007005272U1 Creme, Lotion, o.dgl. Cream, lotion, or the like. |
| 06/28/2007 | DE202007005123U1 Kosmetische, pharmazeutische und/oder dermatologische Zusammensetzungen enthaltend langkettige Fettalkohole und/oder deren Derivate Cosmetic, pharmaceutical and / or dermatological compositions comprising long chain fatty alcohols and / or derivatives thereof |
| 06/28/2007 | DE102005061246A1 Präparate mit niedermolekularen Substanzen aus Dipteren zur Behandlung von Wunden Preparations with low molecular weight substances from Diptera for the treatment of wounds |
| 06/28/2007 | DE102005061071A1 Wirkstoffkombination aus Santalbinsäure oder Derivate davon und Traubenkernöl zur topischen oder dermatologischen Verwendung Combination of active substances santalbic or derivatives thereof, and grape seed oil for topical or dermatological use |
| 06/28/2007 | CA2634824A1 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation |
| 06/28/2007 | CA2634804A1 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 06/28/2007 | CA2634212A1 Mif inhibitors |
| 06/28/2007 | CA2634116A1 Anti-ilt7 antibody |
| 06/28/2007 | CA2633040A1 Composition of inverse emulsion type comprising ivermectin, and uses thereof in cosmetics and dermatology |
| 06/28/2007 | CA2632911A1 Compositions including at least one retinoid compound and at least one anti-irritant compound and uses thereof |
| 06/28/2007 | CA2632902A1 Compositions including at least one retinoid compound and at least one anti-irritant compound and uses thereof |
| 06/28/2007 | CA2632780A1 Combination of r,r-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases |
| 06/28/2007 | CA2628596A1 Estrogen modulators |
| 06/27/2007 | EP1801112A1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 06/27/2007 | EP1801108A1 Morpholine compound |
| 06/27/2007 | EP1800672A1 Pharmaceutical composition and the use therof for the treatment of dermatoses |
| 06/27/2007 | EP1799311A2 Compositions with inhibitors of the synthesis of prostaglandin and/or of leukotriene in conjunction with stimulators of the release of cutaneous neuromediators |
| 06/27/2007 | EP1799254A1 Clostridial neurotoxins for use in tissue healing |
| 06/27/2007 | EP1799245A1 Use of angiotensin-(1-7) for preventing and/or reducing the formation of neointima |
| 06/27/2007 | EP1799228A1 Topical compositions containing phosphorylated polyphenols |
| 06/27/2007 | EP1799213A2 Novel curcumin analogues and uses thereof |
| 06/27/2007 | EP1531812B1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 06/27/2007 | EP1366025B1 Agonists of beta-adrenoreceptors |
| 06/27/2007 | EP1284973B1 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 06/27/2007 | EP1212063B1 Topical azathioprine for the treatment of oral autoimmune diseases |
| 06/27/2007 | EP1047676B1 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 06/27/2007 | EP0863903B1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 06/27/2007 | CN1988883A Scalp and hair-care composition |
| 06/27/2007 | CN1986557A Small interference RNA molecule inhibiting human papillomavirus II and its application |
| 06/27/2007 | CN1985994A Improved enteric medicine composition with mycophenolate |
| 06/27/2007 | CN1985989A Slow released nano microsphere gel of alkaline fibroblast growth factor and polylactic acid and its preparing method |
| 06/27/2007 | CN1985975A Chinese medicine for treating tinea pedis by soaking feet |
| 06/27/2007 | CN1985971A Medicine for treating flat wart and its preparing method |
| 06/27/2007 | CN1985961A Chinese medicine composition for treating facial skin disease and its preparing method |
| 06/27/2007 | CN1985944A Chinese medicine composition for treating cutaneous pruritus, rubella and other diseases |
| 06/27/2007 | CN1985943A Extraction process of aloe gel concentrate |
| 06/27/2007 | CN1985920A Preparation for clearing away heat and toxic matter and its new preparing process |
| 06/27/2007 | CN1985919A Chinese medicine composition for treating facial stain and other endocrinic gynecopathy |
| 06/27/2007 | CN1985911A Burn treating medicine and its preparing method |
| 06/27/2007 | CN1985899A Externally applied medicine for treating burns and scalds and its preparing method |
| 06/27/2007 | CN1985837A High efficiency and low toxicity externally applied medicine preparation of ginsenoside and triamcinolone acetonide |
| 06/27/2007 | CN1985797A Chinese herbal medicine hot spring bath flake and powder and their preparing process |
| 06/27/2007 | CN1985794A Skin repairing cosmetic composition containing plant integration factor and its application |
| 06/27/2007 | CN1322891C Externally applied ointment for treating burns and scalds |
| 06/27/2007 | CN1322867C Hemostatic wound healing Dan |
| 06/26/2007 | USRE39706 Crystalline form of a vitamin D analogue |
| 06/26/2007 | US7235635 IRAK-4: compositions and methods of use |
| 06/26/2007 | US7235561 Compound and a composition including such a compound |
| 06/26/2007 | US7235554 Water soluble; treating diseases in which peripheral benzodiazepine receptors are involved such as spinal amyotrophy, amyotrophic lateral sclerosis, cranial and medullar trauma, multiple sclerosis, and diabetic nephropathy |
| 06/26/2007 | US7235552 Cholenic acid amides and pharmaceutical compositions thereof |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235532 Angiogenic agents and their uses |
| 06/26/2007 | US7235246 Dermatomycosis vaccine |
| 06/26/2007 | US7234582 Coin guiding apparatus |
| 06/26/2007 | CA2455231C Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 06/26/2007 | CA2185037C Iridaceae extract and compositions containing the same |
| 06/21/2007 | WO2007070514A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 06/21/2007 | WO2007070110A2 Oxygen producing device for woundcare |
| 06/21/2007 | WO2007069758A1 Composition having ppar ligand activity |
| 06/21/2007 | WO2007069712A1 Amine compound and use thereof for medical purposes |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007069621A1 Novel composition and method for production thereof |
| 06/21/2007 | WO2007068844A1 Use of a dermatological composition comprising an association of hydroquinone, fluocinolone acetonide and tretinoin for treating skin hyperpigmentation following psoriasis or eczema |